|
|
Other links at Articles > Pharmacists |
| 1. |
Chemotherapy and Tamoxifen Cut Long-Term Risk of Contralateral Breast Cancer
|
|
|
Adjuvant chemotherapy and tamoxifen treatment for primary breast cancer are both independently associated with reduced risks of contralateral breast cancer that persist for up to 10 and 5 years, respectively, after the first cancer diagnosis, according to a report in the Journal of the National Cancer Institute for January 2. Reuters Health Information
|
| 3. |
Bosentan May Offer Modest Benefits for Idiopathic Pulmonary Fibrosis
|
|
|
Bosentan, a dual endothelin receptor antagonist, may be a useful treatment for idiopathic pulmonary fibrosis, especially biopsy-proven disease, according to a report in the American Journal of Respiratory and Critical Care Medicine for January. Reuters Health Information
|
| 5. |
Combination Therapy Best for Benign Prostatic Hyperplasia
|
|
|
Combination therapy with dutasteride (a 5-alpha reductase inhibitor) and tamsulosin (an alpha-blocker) is better than either drug alone for treating lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH), according to a report in the February issue of The Journal of Urology. Reuters Health Information
|
|
|
